Kyle Bass files 15th IPR, targeting patent for Vimovo treatment
The Coalition for Affordable Drugs has filed an inter partes review petition challenging a patent for Pozen’s Vimovo drug, which Horizon Pharma holds the rights to in the US
This is the 15th petition filed by he Coalition, backed by Kyle Bass, his Hayman Capital hedge fund, Erich Spangenberg, nXn Partners, and IP Nav. The petitions have targeted seven companies.
Critics, such as BIO, accuse Bass of using IPR...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.